Sih Partners, Lllp Halozyme Therapeutics, Inc. Transaction History
Sih Partners, Lllp
- $2.95 Trillion
- Q1 2025
A detailed history of Sih Partners, Lllp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Sih Partners, Lllp holds 7,626 shares of HALO stock, worth $414,701. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,626Holding current value
$414,701% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$958 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$698 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$329 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$212 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$200 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.57B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...